Company: SMNR
Filing Date: 2025-08-22
Form Type: 8-K
Source: 0001213900-25-079504
Chunk: 4

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-08-22
Form: 8-K
Item: Item 3.02
Chunk 4
---
 and uncertainties include, but are not limited to,
general economic, political and business conditions; the inability of the parties to consummate the Business Combination or the occurrence
of any event, change or other circumstances that could give rise to the termination of the Merger Agreement; the outcome of any legal
proceedings that may be instituted against the parties following the announcement of the Business Combination; the receipt of an unsolicited
offer from another party for an alternative business transaction that could interfere with the Business Combination; the risk that the
approval of the stockholders of Semnur or the shareholders of Denali for the potential transaction is not obtained; failure to realize
the anticipated benefits of the Business Combination, including as a result of a delay in consummating the potential transaction or difficulty
in integrating the businesses of Semnur or Denali; the risk that the Business Combination disrupts current plans and operations as a
result of the announcement and consummation of the Business Combination; the ability of the combined company to grow and manage growth
profitably and retain its key employees; the amount of redemption requests made by Denali’s shareholders; the inability to obtain
or maintain the listing of the post-acquisition company’s securities on Nasdaq or OTC Markets following the Business Combination;
and costs related to the Business Combination. There may be additional risks that Denali presently does not know or that Denali currently
believes are immaterial that could also cause actual results to differ from those contained in the forward-looking statements. In addition,
forward-looking statements provide Denali’s expectations, plans or forecasts of future events and views as of the date of this
communication. Denali anticipates that subsequent events and developments will cause such assessments to change. However, while Denali
may elect to update these forward-looking statements at some point in the future, Denali specifically disclaims any obligation to do
so. These forward-looking statements should not be relied upon as representing Denali’s assessments as of any date subsequent to
the date of this communication. Accordingly, undue reliance should not be placed upon the forward-looking statements.

No
Offer or Solicitation

This
communication is for informational purposes only and is neither an offer to purchase, nor a solicitation of an offer to sell, subscribe
for or buy any securities or the solicitation of any vote in any jurisdiction pursuant to the Business Combination or otherwise, nor
shall there be any sale, issuance or transfer of securities in any jurisdiction in contravention of applicable law. No offer